Aortic stenosis is a disease often diagnosed in its asymptomatic phase due to its distinct murmur and the widespread use of noninvasive imaging. The history, however, is still of paramount importance ...

WILLIAMSPORT, Pa. — Aortic stenosis is a condition that often develops with age. It's caused by a buildup of calcium, which causes the aortic valve to become too narrow, reducing blood flow from the ...

Studio10’s Krystin Rae is speaking with Dr. Roxana Mehran about Aortic Stenosis. Aortic Stenosis affects the most important valve in our body according to Dr. Mehran. In this segment, they’re talking ...

FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis early in the disease process while patients still had no symptoms or other ...

The burden of severe aortic stenosis in the UK far exceeds the capacity of the NHS to screen or treat the disease, according to a study published this week in Open Heart. The study is the first to ...

In a large cohort of mostly male subjects, people with rheumatoid arthritis (RA) had a higher risk of developing aortic stenosis, needing an aortic valve intervention, or dying of aortic stenosis, ...

WASHINGTON--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) today announced results from the EARLY TAVR Trial, the first randomized, controlled trial designed to study the best strategy for treating ...

University of East Anglia scientists have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and ...

Edwards Lifesciences has claimed a groundbreaking approval from the FDA that opens up its minimally invasive heart valve implants to patients before they begin to show cardiac symptoms. The company ...

Results from the PREVUE-VALVE study suggest that there are currently at least 4.7 million people aged 65–85 living with ...

Please provide your email address to receive an email when new articles are posted on . TAVR was superior to clinical surveillance in patients with asymptomatic severe aortic stenosis. Almost all ...

Edwards Lifesciences (NYSE: EW) today announced new data demonstrating long-term benefits with its Sapien heart valve system.